The human genome project was a major advance, allowing for molecular foothold towards an understanding of human diseases. The question now is “what do these genes do, and how do they participate in human disease?” In my lab we are focused on this issue. We use whole genome, functional in vivo screening in the fruit fly to identify novel conserved disease genes, then we use human genetics data to focus on medically relevant candidates, finally we use knockout mice to functionally validate these n ....The human genome project was a major advance, allowing for molecular foothold towards an understanding of human diseases. The question now is “what do these genes do, and how do they participate in human disease?” In my lab we are focused on this issue. We use whole genome, functional in vivo screening in the fruit fly to identify novel conserved disease genes, then we use human genetics data to focus on medically relevant candidates, finally we use knockout mice to functionally validate these new genesRead moreRead less
The Search For Novel Therapeutic Targets For The Treatment Of Chronic Pain.
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
Chronic pain is very common, with one in five Australians suffering long-term pain that is serious enough to cause disability. It is extraordinarily difficult to treat. Medicines used to treat normal pain symptoms are usually ineffective on chronic pain patients because the cause of the pain is different. The aim of this project is to identify new drug targets in the spinal cord that are specific for chronic pain so we can develop new medicines to reverse the symptoms safely and effectively.
Determining The Mechanisms Underlying Chronic Visceral Pain And Providing Novel Treatment Strategies
Funder
National Health and Medical Research Council
Funding Amount
$415,218.00
Summary
Gastroenteritis activates special types of nerve endings in the gut to cause acute pain. In chronic gut pain, although the damaged tissue has healed, the nerve endings remain active and don’t reset back to normal. This project will identify why this occurs, determining pain mechanisms associated with Irritable Bowel Syndrome, a leading form of chronic pain. It will identify which ion channels and receptors can be targeted allowing the development of novel and effective therapies for pain relief.
Improving Outcomes In Low Back Pain: Targeting Specific Therapies To Patient Subgroups
Funder
National Health and Medical Research Council
Funding Amount
$435,061.00
Summary
Low back pain is a major health problem worldwide. There is a lack of effective treatments and a “one size fits all” approach to treatment is being used. This innovative research program aims to change the way back pain is treated, by identifying specific types of back pain, determining the effectiveness of treatments for these types of back pain, and translating a targeted approach to management into clinical practice to improve the health of individuals with back pain.
Unravelling The Effects Of Physical Activity For Back Pain
Funder
National Health and Medical Research Council
Funding Amount
$476,728.00
Summary
Physical activity is recommended internationally for the treatment of low back pain, but can prove beneficial or harmful. Ensuring it is prescribed safely and effectively is therefore of paramount importance. This research will advance the field by elucidating the relationship between back pain and physical activity. In collaboration with Medibank Private I will design and test e-health physical activity programs to reduce the burden of back pain for urban and rural communities.
An Integrated, Multi-system Approach To Understanding Persistent Pain
Funder
National Health and Medical Research Council
Funding Amount
$419,180.00
Summary
Musculoskeletal pain is a major health problem in Australia, with an economic burden second only to cancer. Despite the scale of the problem, there are few effective treatments. This project examines a range of biological mechanisms that could explain why some people get better over time while others experiencing pain do not. The findings of this research will contribute to the development of new treatments that can be targeted to each individual to improve pain and disability.
Reconsideration Of The Mechanisms Underlying Movement Changes With Pain
Funder
National Health and Medical Research Council
Funding Amount
$401,361.00
Summary
Pain changes the way we move. Although undisputed, there is a surprising lack of agreement regarding the underlying mechanisms. This project involves an innovative mix of neurophysiological methods to investigate how the drive to muscle cells from the nervous system is altered during pain. We aim to resolve the perplexing problem of how pain changes our ability to activate muscle. Our findings are likely to provide a clear understanding of the underlying mechanisms and guide rehabilitation.
Whiplash Injury: Classification, Prediction And Directives For Improved Management Strategies.
Funder
National Health and Medical Research Council
Funding Amount
$331,674.00
Summary
Whiplash is a costly condition with many people developing chronic symptoms. This research aims to improve the diagnosis and classification of the condition from the time of injury until either recovery or the development of persistent pain. This will facilitate the early identification of those at risk of poor recovery and will lay the foundations for the development of improved early management, particularly in primary care.
Tuberculosis - Transmission, Drug Resistance And Strain Emergence
Funder
National Health and Medical Research Council
Funding Amount
$290,652.00
Summary
Tuberculosis (TB) kills nearly 2 million people each year. The emergence of drug resistant TB in the Asia-Pacific region pose a particular threat to Australia, due to frequent population mixing and ongoing TB transmission that may facilitate its spread within vulnerable communities. The proposed study will develop advanced tools to monitor and limit TB transmission within Australia. It will also provide novel insight into the evolution of the global TB epidemic and key factors that sustain it.
There is huge interest in the development of bioactive peptides and proteins for the treatment of a wide range of diseases. However, the biggest challenge in the development of peptide and protein drugs is overcoming their poor stability in the human body. The aim of my research is to develop novel methods that provide therapeutically promising peptides and proteins the ability to resist the body’s natural degradation pathways so they can reach their biological target and act as effective drugs.